Link:  Pharm/Biotech Resources

Title:  Agents for improving lipid metabolism and reducing high blood pressure

United States Patent:  6,929,806

Issued:  August 16, 2005

Inventors:  Toba; Yasuhiro (Musashino, JP); Takada; Yukihiro (Kawagoe, JP); Morita; Yoshikazu (Kawagoe, JP); Abe; Takumi (Kawagoe, JP); Kawakami; Hiroshi (Kawagoe, JP)

Assignee:  Snow Brand Milk Products Co., Ltd. (Hokkai-do, JP)

Appl. No.:  789193

Filed:  February 27, 2004

A milk-derived basic protein fraction and a basic peptide fraction are provided for use as an effective component for agents for improving lipid metabolism and reducing high blood pressure which can be administered orally, are effective with a relatively small dosage, have good taste and are stable during storage.

SUMMARY OF THE INVENTION

The present inventors found that a milk-derived basic protein fraction or a basic peptide fraction, which is obtained by digesting said basic protein fraction with a protease, e.g. pepsin and pancreatin, can improve lipid metabolism and reduce high blood pressure when administered orally. Further, the inventors found that these basic protein fraction and basic peptide fraction can be effectively used as an effective component for agents and drinks or food products for improving lipid metabolism and high blood pressure and the combination thereof.

In one embodiment an agent for improving lipid metabolism is provided comprising a milk-derived basic protein fraction as an effective component and a suitable carrier (e.g., for oral administration). Preferably, this milk-derived basic protein fraction contains 15% or more by weight basic amino acids in its amino acid composition. Preferably, the milk-derived basic protein fraction is obtained by bringing milk or a milk-derived material into contact with cation exchange resins to adsorb basic proteins and eluting a fraction adsorbed on the resins with an eluent having a salt concentration of about 0.1 M to about 1.0 M.

In another embodiment an agent for improving lipid metabolism is provided comprising a basic peptide fraction as an effective component which is obtained by digesting the milk-derived basic protein fraction by a protease. Preferably, the milk-derived basic protein fraction is digested by at least one of proteases selected from the group consisting of pepsin, trypsin, chymotrypsin, and pancreatin.

In another embodiment a drink or food product for improving lipid metabolism is provided to which the milk-derived basic protein fraction or basic peptide fraction of the present invention is admixed.

In another embodiment an agent for reducing high blood pressure is provided comprising a milk-derived basic protein fraction as an effective component and a suitable carrier (e.g., for oral administration). Preferably, this milk-derived basic protein fraction contains 15% or more by weight basic amino acids in its amino acid composition. Preferably, the milk-derived basic protein fraction is obtained by bringing milk or a milk-derived material into contact with cation exchange resins to adsorb basic proteins and eluting a fraction adsorbed on the resins with an eluent having a salt concentration of about 0.1 M to about 1.0 M.

In another embodiment an agent for reducing high blood pressure is provided comprising a basic peptide fraction as an effective component which is obtained by digesting the milk-derived basic protein fraction by a protease. Preferably the milk-derived basic protein fraction is digested by at least one of proteases selected from the group consisting of pepsin, trypsin, chymotrypsin, and pancreatin.

In another embodiment a drink or food product for reducing high blood pressure is provided to which the milk-derived basic protein fraction or basic peptide fraction of the present invention is admixed.

An agent for improving lipid metabolism and an agent for reducing high blood pressure can include basically the same component. By examining activities and effects on each lipid metabolism and blood pressure with respect to the content of the component and other supplemental ingredients, desired balance therebetween can readily be achieved. Agents for improving lipid metabolism and/or reducing high blood pressure of the present invention can be administered not only to a patient having the symptoms but also to a candidate for the treatment of preventing these symptoms.

For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described above. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein. Further aspects, features and advantages of this invention will become apparent from the detailed description of the preferred embodiments which follow.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Agents for improving lipid metabolism and reducing high blood pressure and a combination thereof are characterized in that they contain a milk-derived basic protein fraction or a basic peptide fraction as an effective component. Said milk-derived basic protein fraction can be obtained from mammalian milk such as cow milk, human milk, goat milk, and ewe milk. The basic peptide fraction can be obtained by digesting the milk-derived basic milk fraction of the present invention with a protease.

In an embodiment, this milk-derived basic protein fraction has the following characteristics as described hereinafter in Test Examples 1 through 3. The present invention is not limited to this embodiment.

1) It comprises various proteins having a molecular weight ranging from about 2,000 to about 80,000, preferably from about 3,000 to about 24,000, according to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). It has an isoelectric point ranging from about 7.5 to about 11, preferably from about 8 to about 10.

2) It contains more than about 95% by weight protein and small amounts of fat and ash.

3) Proteins contained are mainly lactoferrin and lactoperoxidase.

4) As for the amino acid composition of proteins, it contains more than about 15% by weight basic amino acids such as lysine, histidine and arginine.

Such a basic protein fraction can be obtained, for example, by bringing a milk material, such as skimmed milk and whey, into contact with cation exchange resins to adsorb basic proteins, eluting a basic protein fraction adsorbed on these resins with an eluent having a salt concentration of about 0.1 M to about 1.0 M, recovering this eluate fraction, desalting and concentrating this fraction with a reverse osmotic (RO) membrane or by the electrodialysis (ED) method, and drying the resulting fraction, if necessary.

Further, a milk-derived basic protein fraction can be obtained, for example, by a method in which milk or milk-derived material is brought into contact with cation exchanger to adsorb basic proteins, and then a basic protein fraction adsorbed on this cation exchanger is eluted with an eluent having a pH higher than 5 and an ionic strength greater than 0.5 (Japanese Patent Application Laid-open No. H5-202098), a method in which alginic acid gel is used (Japanese Patent Application Laid-open No. S61-246198), a method in which the fraction is obtained from whey using inorganic porous particles (Japanese Patent Application Laid-open No. H1-86839), and a method in which the fraction is obtained from milk using a sulfate ester compound (Japanese Patent Application Laid-open No. S63-255300). In the present invention, a basic protein fraction obtained by any of such a method can be used. The disclosure of the above references is herein incorporated by reference.

Further, a milk-derived basic peptide fraction has the same amino acid composition as the basic protein fraction. For example, the milk-derived basic protein fraction obtained by any of the abovementioned methods is treated with protease such as pepsin, trypsin, and chymotrypsin, and if necessary further with protease such as pancreatin, to obtain a peptide composition having an average molecular weight of less than about 4,000, preferably from about 1,000 to about 3,000.

In administering agents of the present invention for improving lipid metabolism and reducing high blood pressure and the combination thereof, a milk-derived basic protein fraction or the basic peptide fraction as an effective component can be used without further processing. Also, the milk-derived basic protein and basic peptide fractions of the present invention can be formulated into powders, granules, tablets, capsules, drinks, or the like according to conventional methods. Further, these basic protein fraction and basic peptide fraction, without further processing or after formulation, can be admixed with nutrients, drinks or food products to improve lipid metabolism and reduce high blood pressure. An increased activity for improving lipid metabolism and reducing high blood pressure and the combination thereof can be expected by admixing the basic protein fraction or the basic peptide fraction of the present invention along with other components which are considered to have an activity to improve lipid metabolism (e.g., 50 to 50,000% by weight with respect to the basic protein fraction or the basic peptide fraction), such as soybean protein, whey protein, soybean lecithin, diacylglycerol, and soybean isoflavone, as well as the other components which are considered to have an antihypertensive activity (e.g., 100 to 50,000% by weight with respect to the basic protein fraction or the basic peptide fraction), such as calcium, magnesium, potassium, and dietary fiber. For example, 10 g of soybean protein and 40 mg of soybean isoflavone can be used with 20 to 100 mg of the milk-derived basic protein fraction. In other examples, 10 g of dietary fiber and 100 mg of magnesium can be used with 20 to 100 mg of the milk-derived basic protein fraction. By adjusting the amounts of the above supplemental components, an activity of improving lipid metabolism and an activity of lowering blood pressure can effectively be balanced. Further, materials containing the milk-derived basic protein fraction or basic peptide fraction of the present invention can be sterilized by heating under ordinary conditions known to a skilled artisan (for example, at 90° C. for 10 min., at 121° C. for 2 sec.) since the milk-derived basic protein fraction and basic peptide fraction of the present invention are relatively heat-stable.

For the purpose of this invention the "effective component" means causing a result, such as the improvement of lipid metabolism, reduction of high blood pressure, or both.

The dosage of agents for improving lipid metabolism and reducing high blood pressure and the combination thereof according to the present invention varies depending on age, therapeutic effect and pathologic conditions. However, results of animal experiments using rats revealed that an administration of 20 mg or more of a basic protein fraction or basic peptide fraction per kg body weight of rat was necessary to improve lipid metabolism and high blood pressure. Therefore, according to an extrapolation method (A Sequel to Medicinal Development, 1993 8:7-18), an effective daily dose for a human adult is estimated to be about 20 mg or more, preferably from about 20 to about 1000 mg, more preferably from about 40 to about 100 mg. Accordingly, the fractions can be admixed with drinks or food products or administered as a medicine so as to securely attain this dosage (for example, 2 m % to 2% in a drink or food product, 0.2% to 20% in a medicine).
 

Claim 1 of 4 Claims

1. A method of improving lipid metabolism and/or reducing high blood pressure comprising administering an effective amount of a milk-derived basic protein fraction to a candidate for the treatment or a patient in need thereof.

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.